Position in VCEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$40,316,835
+$13,141,069 QoQ
Shares Held
906,200
+7.3% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 4%
None 5%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. VCEL ranks #40 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,316,835 | 906,200 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $27,175,766 | 844,755 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $29,370,474 | 815,620 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $25,108,494 | 797,855 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $32,922,806 | 773,744 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $34,242,277 | 767,420 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $41,209,514 | 750,492 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,321,202 | 693,993 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $30,327,504 | 661,018 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $33,356,002 | 641,215 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $26,010,468 | 730,426 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $24,213,036 | 722,346 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $24,923,035 | 663,376 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $16,799,361 | 572,966 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,584,640 | 553,707 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,222,323 | 397,514 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $10,481,652 | 416,269 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $26,744,215 | 699,744 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,906,654 | 710,093 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $36,305,980 | 743,975 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $37,000,845 | 704,778 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $31,300,814 | 563,471 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $15,631,888 | 506,214 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $8,563,695 | 462,153 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,046,111 | 437,490 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,449,433 | 376,165 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||